Nissay Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.45M | Buy |
198,026
+8,450
| +4% | +$459K | 0.04% | 280 |
|
|
2026
Q1 | $11.9M | Buy |
189,576
+2,724
| +1% | +$218K | 0.06% | 195 |
|
|
2025
Q4 | $17.8M | Sell |
186,852
-1,161
| -0.6% | -$114K | 0.09% | 150 |
|
|
2025
Q3 | $18.4M | Buy |
188,013
+2,394
| +1% | +$248K | 0.1% | 141 |
|
|
2025
Q2 | $19.9M | Buy |
185,619
+2,511
| +1% | +$254K | 0.12% | 136 |
|
|
2025
Q1 | $18.5M | Buy |
183,108
+2,380
| +1% | +$240K | 0.12% | 128 |
|
|
2024
Q4 | $16.4M | Sell |
180,728
-2,385
| -1% | -$210K | 0.1% | 139 |
|
|
2024
Q3 | $15.3M | Buy |
183,113
+5,102
| +3% | +$402K | 0.1% | 143 |
|
|
2024
Q2 | $13.7M | Buy |
178,011
+5,612
| +3% | +$411K | 0.09% | 145 |
|
|
2024
Q1 | $11.8M | Sell |
172,399
-1,712
| -1% | -$110K | 0.08% | 163 |
|
|
2023
Q4 | $10.1M | Buy |
174,111
+7,613
| +5% | +$406K | 0.08% | 154 |
|
|
2023
Q3 | $8.79M | Buy |
166,498
+5,306
| +3% | +$278K | 0.08% | 158 |
|
|
2023
Q2 | $8.72M | Buy |
161,192
+274
| +0.2% | +$14.3K | 0.08% | 156 |
|
|
2023
Q1 | $8.05M | Sell |
160,918
-5,643
| -3% | -$266K | 0.07% | 162 |
|
|
2022
Q4 | $7.71M | Sell |
166,561
-52
| -0% | -$2.25K | 0.07% | 164 |
|
|
2022
Q3 | $6.45M | Buy |
166,613
+6,363
| +4% | +$255K | 0.07% | 172 |
|
|
2022
Q2 | $5.97M | Buy |
160,250
+877
| +0.6% | +$35.7K | 0.06% | 183 |
|
|
2022
Q1 | $7.06M | Buy |
159,373
+3,678
| +2% | +$159K | 0.06% | 191 |
|
|
2021
Q4 | $6.61M | Buy |
155,695
+5,261
| +3% | +$221K | 0.05% | 209 |
|
|
2021
Q3 | $6.53M | Buy |
150,434
+6,171
| +4% | +$273K | 0.06% | 195 |
|
|
2021
Q2 | $6.17M | Buy |
144,263
+7,678
| +6% | +$323K | 0.05% | 203 |
|
|
2021
Q1 | $5.28M | Sell |
136,585
-3,254
| -2% | -$123K | 0.05% | 210 |
|
|
2020
Q4 | $5.03M | Buy |
139,839
+743
| +0.5% | +$26.8K | 0.08% | 196 |
|
|
2020
Q3 | $5.32M | Sell |
139,096
-21,247
| -13% | -$819K | 0.09% | 181 |
|
|
2020
Q2 | $5.63M | Buy |
160,343
+1,436
| +0.9% | +$51.7K | 0.11% | 182 |
|
|
2020
Q1 | $5.18M | Buy |
158,907
+4,047
| +3% | +$158K | 0.13% | 165 |
|
|
2019
Q4 | $7M | Sell |
154,860
-5,305
| -3% | -$222K | 0.16% | 159 |
|
|
2019
Q3 | $6.52M | Buy |
160,165
+6,718
| +4% | +$285K | 0.16% | 152 |
|
|
2019
Q2 | $6.59M | Sell |
153,447
-14,490
| -9% | -$557K | 0.17% | 143 |
|
|
2019
Q1 | $6.45M | Sell |
167,937
-7,970
| -5% | -$304K | 0.17% | 144 |
|
|
2018
Q4 | $6.22M | Buy |
175,907
+5,708
| +3% | +$207K | 0.19% | 125 |
|
|
2018
Q3 | $6.55M | Buy |
170,199
+3,679
| +2% | +$128K | 0.18% | 142 |
|
|
2018
Q2 | $5.45M | Sell |
166,520
-1,681
| -1% | -$50.7K | 0.16% | 153 |
|
|
2018
Q1 | $4.59M | Sell |
168,201
-8,189
| -5% | -$223K | 0.14% | 186 |
|
|
2017
Q4 | $4.37M | Buy |
+176,390
| New | +$4.87M | 0.13% | 206 |
|
Other funds holding BSX
Nissay Asset Management's BSX Position: Q2 2026 in Review
Nissay Asset Management increased its Boston Scientific (BSX) stake by 4.5% in Q2 2026, buying an estimated $459K and bringing the position to 198,026 shares worth $8.45M. The position accounts for 0.04% of the portfolio, ranked #280.
Nissay Asset Management first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $19.9M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Nissay Asset Management held 198,026 shares of Boston Scientific worth $8.45M as of Q2 2026.
- Nissay Asset Management bought 8,450 Boston Scientific shares in Q2 2026, an estimated $459K.
- Boston Scientific made up 0.04% of Nissay Asset Management's portfolio in Q2 2026, its #280 holding.
- Nissay Asset Management first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's Boston Scientific position peaked at $19.9M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.